Mankind Pharma launches campaign to inspire 1 crore Indians to pledge for organ donation

In a step towards addressing India’s critical need for organ donors, Mankind Pharma Limited, one of India’s leading pharmaceutical companies, has launched its nationwide public awareness campaign “Angdaan Mahadaan”, with a goal of inspiring 1 crore Indians to pledge for organ donation.

The campaign was launched in the presence of transplant specialists and dignitaries from the National Organ and Tissue Transplant Organisation (NOTTO), who came together to raise public awareness, dispel myths and highlight the transformative impact of organ donation.

Through “Angdaan Mahadaan”, Mankind Pharma aims to create greater awareness, address myths and misconceptions, and motivate millions of Indians to turn public awareness into meaningful action.

The campaign was launched at an Organ Donation Awareness Event hosted by Mankind Pharma, engaging more than 25,000 Mankindians, their families and extended communities. The event featured sessions on the realities of organ donation, myths and facts surrounding transplantation, and the current organ donation landscape in India.

The event brought together Dr D S Ray, chief nephrologist and head, renal transplant programme, R N Tagore International Institute of Cardiac Sciences, Narayana Health, Kolkata; Dr. Abhideep Chaudhary, chairman and HOD, HPB Surgery and Liver Transplantation, BLK-Max Super Speciality Hospital, New Delhi; and Dr. Kanika Rastogi, National Organ and Tissue Transplant Organisation (NOTTO), New Delhi to raise public awareness about the importance of organ donation.

“To give is to live beyond yourself. Through Angdaan Mahadaan, we want to inspire people across India to recognise the extraordinary power of a simple decision: the decision to give someone another chance at life. Our ambition is to motivate 1 crore Indians to pledge for organ donation and make this a movement that creates a lasting legacy of hope,” said Rajeev Juneja, vice chairman and managing director, Mankind Pharma Ltd.

  • Related Posts

    Mankind Pharma to Acquire 70% Stake in Belgium’s ACTx

    Shares of Mankind Pharma fell more than 2% on 16 October after the company announced that it has signed an agreement to acquire a 70% stake in Belgium-based biotechnology company…

    Can a drug licence be suspended before a hearing? Karnataka HC explains rule

    NEW DELHI: Can a drug licensing authority suspend a pharmaceutical distributor’s licence while issuing a show-cause notice, before considering its response? The Karnataka high court has said the procedure under…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Mankind Pharma to Acquire 70% Stake in Belgium’s ACTx

    Mankind Pharma to Acquire 70% Stake in Belgium’s ACTx

    Can a drug licence be suspended before a hearing? Karnataka HC explains rule

    Can a drug licence be suspended before a hearing? Karnataka HC explains rule

    A Boy survives 18th Floor Fall, thanks to Yashoda Medicity

    A Boy survives 18th Floor Fall, thanks to Yashoda Medicity

    AstraZeneca, NIPER Raebareli partner to upgrade 25 clinical trail sites

    AstraZeneca, NIPER Raebareli partner to upgrade 25 clinical trail sites

    FDA clears ImmunityBio’s Anktiva expansion in bladder cancer after regulatory whiplash

    FDA clears ImmunityBio’s Anktiva expansion in bladder cancer after regulatory whiplash

    Sun Pharma Approves Rs 10,000 Crore Fundraising Through NCDs

    Sun Pharma Approves Rs 10,000 Crore Fundraising Through NCDs